Back in 2015; Freedman, Cockburn & Simcoe produced a study (The Economics of Reproducibility in Preclinical Research PLOS Biology, June 9, 2015) which concluded that more the half of all preclinical research in the US can not be reproduced! This caught the the attention of many researchers, almost as much as it did the folks […]